Afeyan Noubar's Form 4 filing
Foghorn Therapeutics Inc. (FHTX) · filed May 24, 2024
- Accession no.
- 0000950170-24-064713
- Filed
- May 24, 2024, 5:05 PM ET
- Trade date
- May 22, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 0 non-derivative transactions and 2 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Afeyan NoubarCIK 0001222012 | 10% Owner |
| Flagship Pioneering, LLCCIK 0001400240 | 10% Owner |
| Flagship Pioneering Special Opportunities Fund II, L.P.CIK 0001761283 | 10% Owner |
| Flagship Pioneering Special Opportunities Fund II General Partner LLCCIK 0001826217 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 22, 2024 | Common Stock | PPurchaseAcquired | +1,814,914 | $5.51 | +$9,999,994.65 | 1,814,914 | Indirect | |
| May 22, 2024 | Common Stock | PPurchaseAcquired | +1,814,915 | $5.51 | +$10,000,000.16 | 1,814,915 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.